QA: Corcept Therapeutics INC in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001088856_2025_Corcept_Therapeutics_INC.pdf

Logs

Graph

Absolute values for 0001088856, Corcept Therapeutics INC

  xvar xval
0 AssetsCurrent 471,602,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,689,000
3 remainder_Assets 366,262,000
4 LiabilitiesCurrent 140,773,000
5 LiabilitiesNoncurrent 6,107,000
6 remainder_Liabilities 14,084,000
7 CostOfGoodsAndServicesSold 11,962,645
8 SellingGeneralAndAdministrativeExpense 340,707,080
9 ResearchAndDevelopmentExpense 230,873,418
10 remainder_Expenses 19,685,378
11 remainder_Revenues 1,637,436,024
12 remainder_NetIncome 35,710,003
13 remainder_ComprehensiveNetIncome 937,426
  yvar yval
0 Assets 840,553,000
1 Liabilities 160,964,000
2 Expenses 603,228,521
3 Revenues 1,637,436,024
4 StockholdersEquity 679,589,000
5 NetIncome 1,069,917,506
6 ComprehensiveNetIncome 1,070,386,219
7 BaseVar 1,639,414,487
8 EconomicCapitalRatiobeforeLimitedLiability 5.10
9 EconomicCapitalRatio 5.27

Edgar->Model Mapping

Feature Distribution

Change over Time